BOULDING MARK ELLIOTT (Exec. VP and CLO) sold 2.6% of their position (2.81K shares) of PTC THERAPEUTICS, INC. on the open market
Open‑market sale worth $204.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/19/2026ACC: 0001578852-26-000022
Officer· Exec. VP and CLO
Since Jan 2019
-2.81K
Net shares
Net seller
$204.1K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
2.81K acquired · 5.63K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+2.81K
Price / share
$25.69
Trade value
$72.27K
% of position
2.7%
8/17/2026
105.27K→108.08K
Common Stock
Direct
Shares
−1.84K
Price / share
$72.39
Trade value
$133.49K
% of position
1.7%
8/17/2026
108.08K→106.24K
Common Stock
Direct
Shares
−969.00
Price / share
$72.90
Trade value
$70.64K
% of position
0.9%
8/17/2026
106.24K→105.27K
Total
Net shares
+0.00
Net value
-$131.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/17/2026 | M · Option Exercise | +2.81K | $25.69 | $72.27K | 2.7% | 105.27K | 108.08K |
| Common Stock Direct | 8/17/2026 | S · Sale | −1.84K | $72.39 | $133.49K | 1.7% | 108.08K | 106.24K |
| Common Stock Direct | 8/17/2026 | S · Sale | −969.00 | $72.90 | $70.64K | 0.9% | 106.24K | 105.27K |
| Total | +0.00 | -$131.86K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.81K shares
Shares
−2.81K
Strike price
25.69
Held after
16.88K
Exercisable
—
8/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock2.81K shares | 8/17/2026 | M · Option Exercise | −2.81K | 25.69 | — | 16.88K |